Drugs that are proven in clinical trials to be beneficial in heart failure, such as beta blockers and angiotensin converting enzyme inhibitors, also show a reduction of serum levels of NTproBNP [19,20,21,34,35]. The gene discussed is ACE; the disease is heart failure.